summary
Introduced
02/26/2026
02/26/2026
In Committee
02/26/2026
02/26/2026
Crossed Over
Passed
Dead
Introduced Session
94th Legislature 2025-2026
Bill Summary
A bill for an act relating to health; establishing a psilocybin therapeutic use program; establishing protections for registered patients, designated cultivators, registered facilitators, and health care practitioners; authorizing rulemaking; authorizing civil actions; establishing fees; classifying data; establishing an advisory committee; providing criminal penalties; appropriating money; proposing coding for new law in Minnesota Statutes, chapter 152.
AI Summary
This bill establishes a legal framework for the therapeutic use of psilocybin, a psychoactive compound found in certain mushrooms, for individuals aged 21 and older who have a diagnosed qualifying medical condition and meet other program requirements. The program, overseen by the commissioner of health, allows registered patients to cultivate psilocybin for personal use or designate a cultivator, and to use psilocybin under the supervision of a registered facilitator during supervised "administration sessions." These sessions are preceded by "preparation sessions" and followed by "integration sessions" with the facilitator. The bill also defines terms like "health care practitioner" (a licensed physician, advanced practice registered nurse, or physician assistant), "designated cultivator" (an individual authorized to grow psilocybin for a registered patient), and "qualifying medical condition" (a condition designated by the commissioner for which psilocybin is a suitable therapy). It outlines eligibility criteria, including health screenings to identify contraindications and requires informed consent from patients. The bill also establishes protections for registered patients, cultivators, facilitators, and healthcare practitioners, and sets limitations on psilocybin use, such as prohibiting use in motor vehicles or public places, and outlines criminal and civil penalties for violations, including diversion of psilocybin. Furthermore, it mandates public education on responsible use and harm reduction, and creates a Psychedelic Medicine Advisory Committee to guide the program's implementation.
Committee Categories
Health and Social Services
Sponsors (4)
Last Action
Author added Port (on 04/07/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.revisor.mn.gov/bills/94/2026/0/SF/3971/ |
| BillText | https://www.revisor.mn.gov/bills/94/2026/0/SF/3971/versions/0/pdf/ |
Loading...